Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose PK and Tolerability of Benapenem in Healthy Subjects
NCT04200261Phase 1Unknown
- Sponsor
- Sihuan Pharmaceutical
- Start
- Dec 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of benapenem in bacterial infection (3 arms), sponsored by Sihuan Pharmaceutical. Primary endpoints: Area under the plasma concentration-time curve from time zero to time t at 192 hours, Maximum observed plasma concentration at 192 hours and 2 more. Status: unknown.
02
Drugs
benapenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04200261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04200261.